• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV蛋白酶同源建模的评估

Evaluation of homology modeling of HIV protease.

作者信息

Weber I T

机构信息

Crystallography Laboratory, NCI-Frederick Cancer Research Facility, Maryland 21701.

出版信息

Proteins. 1990;7(2):172-84. doi: 10.1002/prot.340070206.

DOI:10.1002/prot.340070206
PMID:2158092
Abstract

The model of human immunodeficiency virus (HIV-1) protease which was based on the crystal structure of Rous sarcoma virus (RSV) protease has been compared to the recently determined crystal structure of chemically synthesized HIV-1 protease. The overall difference between the model and crystal structure was 1.4 A root mean square (rms) deviation for 86 superimposed C alpha atoms. The position of the flexible flap differs in the model and six residues at the amino terminus were incorrectly placed. With these exceptions, all atoms of the model and crystal structure agree to 2.1 A rms deviation. The conformation of some surface bends in the model agrees less well with the crystal structure. Identical amino acids in RSV and HIV proteases were modeled more reliably than different types of amino acids. The amino acids which form the substrate binding site were modeled most accurately to 1.2 A rms deviation for all atoms compared to the crystal structure. This suggests that functionally significant regions of related proteins can be modeled with high accuracy. The model gave correct predictions for residues making interactions with the substrate, and therefore could be used to design inhibitors. The model based on the RSV protease structure is more similar to the experimental structure than are previous models based on the structures of non-viral aspartic proteases.

摘要

基于劳斯肉瘤病毒(RSV)蛋白酶晶体结构构建的人类免疫缺陷病毒(HIV-1)蛋白酶模型,已与最近测定的化学合成HIV-1蛋白酶晶体结构进行了比较。该模型与晶体结构之间的总体差异为86个叠加的Cα原子的均方根(rms)偏差1.4 Å。柔性瓣的位置在模型中有所不同,并且氨基末端的六个残基放置错误。除了这些例外,模型和晶体结构的所有原子在2.1 Å的均方根偏差内是一致的。模型中一些表面弯曲的构象与晶体结构的吻合度较低。RSV和HIV蛋白酶中相同的氨基酸比不同类型的氨基酸建模得更可靠。与晶体结构相比,形成底物结合位点的氨基酸对所有原子的建模最为准确,均方根偏差为1.2 Å。这表明相关蛋白质的功能重要区域可以高精度建模。该模型对与底物相互作用的残基做出了正确预测,因此可用于设计抑制剂。与基于非病毒天冬氨酸蛋白酶结构的先前模型相比,基于RSV蛋白酶结构的模型与实验结构更为相似。

相似文献

1
Evaluation of homology modeling of HIV protease.HIV蛋白酶同源建模的评估
Proteins. 1990;7(2):172-84. doi: 10.1002/prot.340070206.
2
Crystal structure of a retroviral protease proves relationship to aspartic protease family.一种逆转录病毒蛋白酶的晶体结构证明了其与天冬氨酸蛋白酶家族的关系。
Nature. 1989 Feb 9;337(6207):576-9. doi: 10.1038/337576a0.
3
Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases.HIV-1和HIV-2蛋白酶的序列与结构比较分析
Proteins. 1991;10(4):325-39. doi: 10.1002/prot.340100406.
4
Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.人类免疫缺陷病毒1型感染的母婴中,HIV-1蛋白酶、Gag p7和p6以及gag/pol多蛋白内蛋白酶切割位点的自然变异:无蛋白酶抑制剂情况下的氨基酸替代
Virology. 1996 May 15;219(2):407-16. doi: 10.1006/viro.1996.0266.
5
Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.源自HIV-1 Vif的肽:一种新型的非基于底物的HIV-1蛋白酶抑制剂。
J Mol Biol. 1999 Mar 19;287(1):93-101. doi: 10.1006/jmbi.1998.2585.
6
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1.人类免疫缺陷病毒HIV-1天冬氨酸蛋白酶的三维结构
Nature. 1989 Feb 16;337(6208):615-20. doi: 10.1038/337615a0.
7
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease.逆转录病毒蛋白酶的保守折叠:合成HIV-1蛋白酶的晶体结构
Science. 1989 Aug 11;245(4918):616-21. doi: 10.1126/science.2548279.
8
A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.人类免疫缺陷病毒1型蛋白酶瓣48位的侧链提供了一个额外的特异性决定因素。
Virology. 1995 Mar 10;207(2):475-85. doi: 10.1006/viro.1995.1107.
9
Structural studies of the retroviral proteinase from avian myeloblastosis associated virus.禽成髓细胞瘤相关病毒逆转录病毒蛋白酶的结构研究。
Proteins. 1992 Nov;14(3):382-91. doi: 10.1002/prot.340140307.
10
How inaccuracies in protein structure models affect estimates of protein-ligand interactions: computational analysis of HIV-I protease inhibitor binding.蛋白质结构模型中的误差如何影响蛋白质-配体相互作用的估计:HIV-1蛋白酶抑制剂结合的计算分析
Proteins. 2006 Nov 1;65(2):407-23. doi: 10.1002/prot.21096.

引用本文的文献

1
Using computer-generated protein models to analyze mutations linked to Amelogenesis Imperfecta.使用计算机生成的蛋白质模型分析与牙釉质发育不全相关的突变。
PLoS One. 2025 Jun 26;20(6):e0326679. doi: 10.1371/journal.pone.0326679. eCollection 2025.
2
A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy.一个调控自噬作用的蛋白聚糖和基质分子的功能外向信号转导网络。
Matrix Biol. 2021 Jun;100-101:118-149. doi: 10.1016/j.matbio.2021.04.001. Epub 2021 Apr 7.
3
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.
洞察 FDA 批准的 HIV PR 药物与 L38L↑N↑L PR 突变体的分子相互作用。
J Comput Aided Mol Des. 2018 Mar;32(3):459-471. doi: 10.1007/s10822-018-0099-9. Epub 2018 Feb 3.
4
Homology modeling a fast tool for drug discovery: current perspectives.同源建模:药物发现的快速工具——当前观点
Indian J Pharm Sci. 2012 Jan;74(1):1-17. doi: 10.4103/0250-474X.102537.
5
SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling.SCWRL和MolIDE:用于侧链构象预测和同源建模的计算机程序。
Nat Protoc. 2008;3(12):1832-47. doi: 10.1038/nprot.2008.184.
6
Advances in homology protein structure modeling.同源蛋白结构建模的进展。
Curr Protein Pept Sci. 2006 Jun;7(3):217-27. doi: 10.2174/138920306777452312.
7
G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin.G蛋白偶联受体药物研发:视紫红质晶体结构带来的启示
Curr Opin Drug Discov Devel. 2001 Sep;4(5):561-74.
8
Structure-based inhibitor design by using protein models for the development of antiparasitic agents.利用蛋白质模型进行基于结构的抑制剂设计以开发抗寄生虫药物。
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3583-7. doi: 10.1073/pnas.90.8.3583.
9
Three-dimensional structural model of the serine receptor ligand-binding domain.丝氨酸受体配体结合域的三维结构模型
Protein Sci. 1993 Apr;2(4):559-66. doi: 10.1002/pro.5560020407.
10
A comparison of the predicted and X-ray structures of angiogenin. Implications for further studies of model building of homologous proteins.血管生成素预测结构与X射线结构的比较。对同源蛋白质模型构建进一步研究的启示。
J Protein Chem. 1994 Oct;13(7):649-58. doi: 10.1007/BF01890464.